2284 related articles for article (PubMed ID: 20724638)
1. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Li N; Lee B; Liu RJ; Banasr M; Dwyer JM; Iwata M; Li XY; Aghajanian G; Duman RS
Science; 2010 Aug; 329(5994):959-64. PubMed ID: 20724638
[TBL] [Abstract][Full Text] [Related]
2. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.
Li N; Liu RJ; Dwyer JM; Banasr M; Lee B; Son H; Li XY; Aghajanian G; Duman RS
Biol Psychiatry; 2011 Apr; 69(8):754-61. PubMed ID: 21292242
[TBL] [Abstract][Full Text] [Related]
3. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists.
Duman RS; Li N
Philos Trans R Soc Lond B Biol Sci; 2012 Sep; 367(1601):2475-84. PubMed ID: 22826346
[TBL] [Abstract][Full Text] [Related]
4. Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses.
Voleti B; Navarria A; Liu RJ; Banasr M; Li N; Terwilliger R; Sanacora G; Eid T; Aghajanian G; Duman RS
Biol Psychiatry; 2013 Nov; 74(10):742-9. PubMed ID: 23751205
[TBL] [Abstract][Full Text] [Related]
5. Signaling pathways underlying the rapid antidepressant actions of ketamine.
Duman RS; Li N; Liu RJ; Duric V; Aghajanian G
Neuropharmacology; 2012 Jan; 62(1):35-41. PubMed ID: 21907221
[TBL] [Abstract][Full Text] [Related]
6. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C
Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
[TBL] [Abstract][Full Text] [Related]
7. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.
Liu RJ; Fuchikami M; Dwyer JM; Lepack AE; Duman RS; Aghajanian GK
Neuropsychopharmacology; 2013 Oct; 38(11):2268-77. PubMed ID: 23680942
[TBL] [Abstract][Full Text] [Related]
8. Ifenprodil rapidly ameliorates depressive-like behaviors, activates mTOR signaling and modulates proinflammatory cytokines in the hippocampus of CUMS rats.
Yao Y; Ju P; Liu H; Wu X; Niu Z; Zhu Y; Zhang C; Fang Y
Psychopharmacology (Berl); 2020 May; 237(5):1421-1433. PubMed ID: 32130432
[TBL] [Abstract][Full Text] [Related]
9. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
[TBL] [Abstract][Full Text] [Related]
10. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice.
Tang J; Xue W; Xia B; Ren L; Tao W; Chen C; Zhang H; Wu R; Wang Q; Wu H; Duan J; Chen G
Sci Rep; 2015 Aug; 5():13573. PubMed ID: 26315757
[TBL] [Abstract][Full Text] [Related]
11. GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine.
Miller OH; Yang L; Wang CC; Hargroder EA; Zhang Y; Delpire E; Hall BJ
Elife; 2014 Oct; 3():e03581. PubMed ID: 25340958
[TBL] [Abstract][Full Text] [Related]
12. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
[TBL] [Abstract][Full Text] [Related]
13. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation.
Harraz MM; Tyagi R; Cortés P; Snyder SH
Mol Psychiatry; 2016 Mar; 21(3):313-9. PubMed ID: 26782056
[TBL] [Abstract][Full Text] [Related]
15. Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms.
Wei IH; Chen KT; Tsai MH; Wu CH; Lane HY; Huang CC
J Agric Food Chem; 2017 Dec; 65(49):10792-10803. PubMed ID: 29161812
[TBL] [Abstract][Full Text] [Related]
16. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Autry AE; Adachi M; Nosyreva E; Na ES; Los MF; Cheng PF; Kavalali ET; Monteggia LM
Nature; 2011 Jun; 475(7354):91-5. PubMed ID: 21677641
[TBL] [Abstract][Full Text] [Related]
17. GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine.
Liu RJ; Duman C; Kato T; Hare B; Lopresto D; Bang E; Burgdorf J; Moskal J; Taylor J; Aghajanian G; Duman RS
Neuropsychopharmacology; 2017 May; 42(6):1231-1242. PubMed ID: 27634355
[TBL] [Abstract][Full Text] [Related]
18. The role of mTOR in depression and antidepressant responses.
Abelaira HM; Réus GZ; Neotti MV; Quevedo J
Life Sci; 2014 Apr; 101(1-2):10-4. PubMed ID: 24582593
[TBL] [Abstract][Full Text] [Related]
19. Effects of ketamine administration on mTOR and reticulum stress signaling pathways in the brain after the infusion of rapamycin into prefrontal cortex.
Abelaira HM; Réus GZ; Ignácio ZM; Dos Santos MA; de Moura AB; Matos D; Demo JP; da Silva JB; Michels M; Abatti M; Sonai B; Dal Pizzol F; Carvalho AF; Quevedo J
J Psychiatr Res; 2017 Apr; 87():81-87. PubMed ID: 28017918
[TBL] [Abstract][Full Text] [Related]
20. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats.
Pałucha-Poniewiera A; Szewczyk B; Pilc A
Neuropharmacology; 2014 Jul; 82():59-68. PubMed ID: 24631968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
